MedPath

Progressing factors of nonalcoholic fatty liver disease(NAFLD)by gene analysis of serial liver biopsies.

Not Applicable
Conditions
onalcoholic fatty liver disease (NAFLD) Nonalcoholic steatohepatitis (NASH) Type 2 diabetes mellitus
Registration Number
JPRN-UMIN000035231
Lead Sponsor
Kanazawa university hospital Department of Endocrinology and metabolism
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up continuing
Sex
All
Target Recruitment
121
Inclusion Criteria

Not provided

Exclusion Criteria

1.Younger than 20 years old

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
To clarify the relationship between hepatic the gene expression by serial liver biopsies and peripheral blood leukocytes in NAFLD patients.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath